Skip to main content
Premium Trial:

Request an Annual Quote

The Sound of a Bubble Bursting

At Eye on DNA, Hsien-Hsien Lei comments on the fact that deCode just laid off 15 percent of its staff. She finds it's surprising, given their number of products and the fact that genomic technologies are becoming cheaper and cheaper. "Perhaps this is an indication that the market is starting to experience saturation in the number of companies and services being offered yet has not seen a concomitant rise in the number of consumers willing to pay for personal genomic services," she says, adding her prediction that in 2008, "we will surely see companies drop out and others consolidate."

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.